AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020
Dec 22, 2020
30339_dirs_2020-12-22_33ab8c8a-0abc-4afd-b2ef-8e05176aad7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-12-08
Reporting Person: MacKay Kimberly Banks (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $275.39 | 2030-02-20 | Common Stock (2360.00) | Direct |
Footnotes
F1: This award vests in four equal installments beginning on December 2, 2021.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12